Cargando…
Metabolomic Analysis Reveals the Therapeutic Effects of MBT1805, a Novel Pan-Peroxisome Proliferator-Activated Receptor Agonist, on α-Naphthylisothiocyanate-Induced Cholestasis in Mice
Background and Aims: Therapeutic drugs that are used to treat cholestatic liver disease are limited; however, the results of clinical trials on primary biliary cholangitis treatment targeting peroxisome proliferator-activated receptors (PPARs) are encouraging. In this study, we aimed to identify the...
Autores principales: | Wang, Chang, Peng, Fei, Zhong, Bohua, Shi, Ying, Wang, Xiaomei, Jin, Xueyuan, Niu, Junqi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8585842/ https://www.ncbi.nlm.nih.gov/pubmed/34776958 http://dx.doi.org/10.3389/fphar.2021.732478 |
Ejemplares similares
-
Glycyrrhetinic Acid Protects α-Naphthylisothiocyanate- Induced Cholestasis Through Regulating Transporters, Inflammation and Apoptosis
por: Yan, Miao, et al.
Publicado: (2021) -
Huangqi Decoction Alleviates Alpha-Naphthylisothiocyanate Induced Intrahepatic Cholestasis by Reversing Disordered Bile Acid and Glutathione Homeostasis in Mice
por: Wu, Jia-Sheng, et al.
Publicado: (2017) -
Yinchenhao Decoction Ameliorates Alpha-Naphthylisothiocyanate Induced Intrahepatic Cholestasis in Rats by Regulating Phase II Metabolic Enzymes and Transporters
por: Yi, Ya-Xiong, et al.
Publicado: (2018) -
Herbal medicine Yinchenhaotang protects against α-naphthylisothiocyanate-induced cholestasis in rats
por: Yan, Jingyu, et al.
Publicado: (2017) -
Danning tablets attenuates α-naphthylisothiocyanate-induced cholestasis by modulating the expression of transporters and metabolic enzymes
por: Ding, Lili, et al.
Publicado: (2014)